Aller au contenu principal
Accès ouvert déclaré 2026 article

Pre-treatment T cell features and immune-milieu characteristics shape treatment-induced exhaustion and resistance to Blinatumomab in B-cell acute lymphoblastic leukemia

0Citations signalées — pas une note de qualité
9Institutions déclarées
3Pays d’affiliation déclarés

Résumé fourni par la source

Background Blinatumomab (Blina), a CD19×CD3 bispecific T cell engager, is approved for the treatment of B-cell precursor acute lymphoblastic leukemia (BCP-ALL), yet resistance remains a major challenge and the mechanisms driving treatment failure remain poorly understood. Methods To define the immunological determinants of resistance, we performed longitudinal profiling of peripheral blood T cells and the immune milieu of 34 patients receiving Blina using flow cytometry (n=19), single-cell CITE-seq (n=13), ex vivo Blina-induced cytotoxicity (n=26) and serum proteomics (n=17). Results At baseline, Responders (R) were enriched for CD8 + effector memory T cells (T EM ) expressing higher levels of cytotoxic genes and their transcriptional regulator ZNF683 . Conversely, CD8 + T EM from Non-Responders (NR) displayed transcriptional features of activation without proportionate cytotoxic commitment. Over the course of the first treatment cycle, NR exhibited a progressive expansion of TIM3 + CD8 + T cells that correlated with a rapid loss of ex vivo cytotoxic function. Linking baseline state to post-treatment T-cell exhaustion, the magnitude of TIM3 + CD8 + expansion correlated inversely with baseline ZNF683 expression in CD8 + T EM . Beyond T-cell-intrinsic features, NR harbored an immunosuppressive milieu characterized by higher circulating levels of M2-polarizing factors (CSF-1, HGF) and the TIM-3 ligand Galectin-9, which correlated positively with the magnitude of TIM3 + CD8 + T-cell expansion. Conclusions These findings indicate that post-Blina CD8 + T-cell exhaustion is associated with resistance and it is shaped by both reduced ZNF683 -dependent cytotoxic programming in CD8 + T EM and an immunosuppressive milieu. This provides a rationale for risk stratification based on baseline transcriptional profiling of CD8 + T EM and for combinatorial strategies targeting the suppressive microenvironment.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Pre-treatment T cell features and immune-milieu characteristics shape treatment-induced exhaustion and resistance to Blinatumomab in B-cell acute lymphoblastic leukemia
Date Crossref
20/08/2026
Éditeur
Frontiers Media SA
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude et ne compte pas comme une seconde source scientifique indépendante.

Institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Sujets associés

Galectins and Cancer BiologyCAR-T cell therapy researchSignaling Pathways in Disease

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.